Dana-Farber ends 2017 with $36.8M operating loss

Boston-based Dana-Farber Cancer Institute ended 2017 with an operating loss of $36.8 million, compared to operating income of $29.7 million in the year prior.

Advertisement

Dana-Farber saw revenues increase 8.4 percent year over year to $1.52 billion in 2017, according to recently released bondholder documents. The hospital’s patient service revenue and research revenue grew 6 percent and 12.3 percent, respectively, year over year.

Higher expenses offset the hospital’s revenue gains. In 2017, Dana-Farber recorded operating expenses of $1.56 billion. That’s up from $1.38 billion in the year prior.

After factoring in strong investment gains, Dana-Farber ended 2017 with net income of $21.2 million, compared to $36.8 million in 2016.

More articles on healthcare finance:

Miami hospital files for bankruptcy: 4 things to know
Moody’s: Nursing shortage will pressure hospital margins for years
Wisconsin hospital at risk of losing Medicare contract over injuries to babies

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.